Inhibitor Therapeutics, Inc.
INTI · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$712 | -$660 | -$633 | -$1,422 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $23 | $0 | $0 |
| Change in WC | $11 | $7 | -$11 | $650 |
| Other Non-Cash | -$61 | $45 | -$641 | $0 |
| Operating Cash Flow | -$761 | -$584 | -$1,285 | -$771 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$761 | -$584 | -$1,285 | -$771 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,738 | $4,322 | $5,607 | $6,378 |
| End Cash | $2,977 | $3,738 | $4,322 | $5,607 |
| Free Cash Flow | -$761 | -$584 | -$1,285 | -$771 |